Market Research Report Store Global Rivaroxaban Market by Manufacturers, Region

Market Research Report Store adds ＂ Global Rivaroxaban Market by Manufacturers, Regions,
Type and Application, Forecast to 2022＂to its research database.The Report consists of players,
geography,type and application.The research analysts also provide an elaborate description of
sales, market share,revenue,growth rate and forecast until 2022.
Description
Rivaroxaban is an oral anticoagulant invented and manufactured by Bayer; in a number of
countries it is marketed as Xarelto. In the United States, it is marketed by Janssen Pharmaceutica. It is
the first available orally active direct factor Xa inhibitor. Rivaroxaban is well absorbed from the gut
and maximum inhibition of factor Xa occurs four hours after a dose. The effects last approximately
8–12 hours, but factor Xa activity does not return to normal within 24 hours so once-daily dosing is
possible.
Scope of the Report:
This report focuses on the Rivaroxaban in Global market, especially in North America, Europe
and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on
manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Bayer
J&J
Market Segment by Regions, regional analysis covers
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Columbia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)